BMN 110
MOR-100
Phase 2 small_molecule terminated
Quick answer
BMN 110 for MPS IV A is a Phase 2 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- MPS IV A
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated